North Carolina 2025-2026 Regular Session

North Carolina House Bill H820

Introduced
4/8/25  
Refer
4/9/25  
Report Pass
4/16/25  

Caption

Prescription Eye Drop Early Refill Coverage

Impact

The implementation of HB 820 is set to influence state law by modifying existing insurance coverage mandates, specifically aiming to improve the management of eye health. By requiring insurers to cover early refills, the bill addresses potential delays in treatment and supports patients who may require timely access to their medication due to various conditions like glaucoma or post-surgery healing. This change is expected to benefit patients significantly, ensuring they have uninterrupted access to essential medications.

Summary

House Bill 820, titled 'Prescription Eye Drop Early Refill Coverage', mandates that health benefit plans in North Carolina that provide coverage for prescription eye drops must also allow for early refills under certain conditions. Specifically, the bill requires insurers to not deny a refill request if the patient has utilized at least 70% of the prescribed dosage or 21 days have passed since the original or most recent refill. This legislative effort seeks to enhance patient access to necessary medications, particularly for those requiring ongoing treatment for eye conditions.

Sentiment

The sentiment surrounding HB 820 appears generally positive, particularly among healthcare providers and patient advocacy groups who support the need for timely access to medications. Proponents argue that the bill is a step forward in patient-centric healthcare, emphasizing the necessity of responsive medical care. However, some concerns may arise from insurance providers regarding the potential for increased costs and the management of prescription refills.

Contention

Notably, points of contention around the bill may include potential implications for insurance costs and the compliance burdens it places on providers. While the intent is to prioritize patient care, insurers could argue the bill may lead to over-prescription or misuse of early refill provisions if not managed correctly. The balance between cost management and patient care will likely be a critical area of discussion as the bill progresses.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.